Daiichi Sankyo approached the Delhi High Court on Wednesday, pressing for the appointment of an external auditor to scrutinise the assets of former Ranbaxy promoters Malvinder Singh and Shivinder Singh. The application seeks to conclusively determine, whether the Singh brothers are in a position to pay the Rs 2,562 crore Singapore arbitration award in favour of the Japanese pharmaceutical major. Wednesday's move follows Daiichi's allegations of false asset declarations made by the Singh brothers on affidavit, when compared to auditor reports of their holding company (RHC Holdings) and other relevant sources. Claiming a Rs 1,500 discrepancy in the figures, Daiichi has stated that a majority of the former Ranbaxy promoters' assets are unrealisable, encumbered and of related and unlisted parties. The Japanese company has also mentioned that this discrepancy is contrary to express undertakings made by the Singh brothers that two of their companies (RHC Holdings and Oscar Investments) had .
